ESTEVE
LIVE

Serial Number

79382728

Owner

ESTEVE PHARMACEUTICALS, S.A.

Attorney

Todd A. Sullivan

Filing Date

Jul 25, 2023

Add to watchlist:

No watchlists yet
View on USPTO

ESTEVE Trademark

Serial Number: 79382728 • Registration: 7998216

ESTEVE is a trademark filed by ESTEVE PHARMACEUTICALS, S.A. on July 25, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

ESTEVE PHARMACEUTICALS, S.A. (26 trademarks)

TORRE ESTEVE,

Entity Type: 99

Trademark Details

Filing Date

July 25, 2023

Registration Date

October 28, 2025

Published for Opposition

September 9, 2025

Goods & Services

Chemical products for use in industry, science, photography, as well as in agriculture, horticulture and forestry, except fungicides, herbicides, insecticides and parasiticides; unprocessed artificial resins, unprocessed plastics; manures for soils; fire extinguishing compositions; tempering and soldering preparations; chemical products for preserving foodstuffs; adhesives for use in industry; chemical test paper; bacterial preparations other than for medical or veterinary use; cultures of microorganisms other than for medical or veterinary use

Pharmaceutical, veterinary and sanitary products for the treatment and prevention of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; anti-inflammatories, analgesics; sanitary preparations for medical purposes; vaccines; dietetic foodstuffs and dietary supplements for humans, both adapted for medical use; food for babies; medical plasters, materials for dressings being bandages for dressings; materials for filling teeth and dental impressions; disinfectants; fungicides, herbicides; starch for dietetic or pharmaceutical purposes; Tobacco-free cigarettes for smoking cessation purposes; caustic pencils; blood plasma; blood for medical use; leeches for medical use; adhesives for dentures; semen for artificial insemination; pharmaceutical preparations for use in treating headaches in the nature of applications in stick form for headache relief; nutritive substances for microorganisms for medical use

Medical research, pharmaceutical research and scientific research services

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
May 21, 2026 FINO
FINAL DISPOSITION NOTICE SENT TO IB
May 6, 2026 FICS
FINAL DISPOSITION PROCESSED
May 6, 2026 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 28, 2026 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Oct 28, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Oct 28, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 9, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 9, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 9, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 4, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 4, 2025 TROA
REFUSAL PROCESSED BY IB
May 17, 2025 RFNT
ATTORNEY REVIEW COMPLETED
May 13, 2025 ATRV
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 30, 2025 RFCS
REFUSAL PROCESSED BY MPU
Apr 30, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 30, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 29, 2025 CNRT
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 26, 2025 OPNX
ATTORNEY REVIEW COMPLETED
Apr 25, 2025 ATRV
LIMITATION FROM THE IB - REQUEST EXAM REVIEW
Apr 16, 2025 LIME
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2025 OPNR
LIMITATION OF GOODS RECEIVED FROM IB
Oct 11, 2024 LIMG
CORRECTION SENT TO IB
Jun 18, 2024 CRSN
CORRECTION CREATED FOR IB
Jun 12, 2024 CRCR
ASSIGNED TO EXAMINER
Mar 27, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 18, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 14, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 9, 2023 REPR